Broader Analyst Sentiment Bullish on Merck & Co. (MRK) Amid Tempered Short-Term Expectation and Long-Term Optimism

Merck & Co., Inc. (NYSE:MRK) is included successful our database of the 10 Goldman Sachs undervalued stocks to put in.

As of January 16, 2026, expert sentiment connected Merck & Co., Inc. (NYSE:MRK) stands broadly constructive, with astir 60% of analysts bullish. However, the $115.00 statement terms people implies a humble 3.60% upside. The broader sentiment reflects tempered short-term expectations contempt semipermanent optimism.

Its healthier longer-term outlook was discussed successful Wolfe Research’s January 8, 2026, update, erstwhile the steadfast upgraded Merck & Co., Inc. (NYSE:MRK) from ‘Peer Perform’ to ‘Outperform’ and raised the terms people to $135.00. The steadfast updated its valuation model, factoring successful the company’s late-stage pipeline, imaginable statement expansions, and prescriber feedback. Citing exemplary updates, the steadfast saw an charismatic five-year gross span and predicted the banal is acceptable to surge, acknowledgment to accretive M&A and a favorable catalyst trajectory.

The affirmative expert stance was reinforced connected the strategical front, with Reuters reporting connected January 8, 2026, that Merck & Co., Inc. (NYSE:MRK) is exploring the imaginable acquisition of crab cause developer Revolution Medicines. The imaginable $28-$32 cardinal deal, the largest pharma transaction successful the past 3 years, volition fortify the company’s oncology pipeline, with Keytruda patent risks expected aboriginal successful the decade.

Merck & Co., Inc. (NYSE:MRK), a planetary healthcare company, focuses connected medicine medicines, vaccines, biologics, and carnal wellness products. The institution boasts a beardown oncology franchise, alongside an expanding late-stage pipeline crossed aggregate therapeutic areas.

While we admit the imaginable of MRK arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 7 Best Rising Tech Stocks to Buy Now and 12 Best Multibagger Stocks to Buy Heading into 2026.

Disclosure: None.